Balrampur Chini Mills Limited reported a strong Fiscal Year 2026, achieving a total standalone income of ₹630,795.91 lakh. The company saw a net profit of ₹34,721.74 lakh for the year. Additionally, the Board approved the re-appointment of Mr. Vivek Saraogi as Chairman and Managing Director, and Ms. Avantika Saraogi as Executive Director for further five-year terms, reinforcing the company’s long-term leadership stability.
Financial Performance Overview
For the financial year ended March 31, 2026, the company delivered robust financial results. The standalone revenue from operations reached ₹627,114.65 lakh, representing significant growth. The company’s focus on its core sugar business and its diversified segments, including distillery and polylactic acid (PLA), contributed to a profit before tax of ₹52,369.48 lakh. Earnings per share (EPS) for the year stood at ₹17.19 (basic).
Strategic Leadership Developments
The Board of Directors has demonstrated a commitment to leadership continuity by approving the re-appointment of key executives. Mr. Vivek Saraogi, a veteran in the industry, will continue his tenure as Chairman and Managing Director for five consecutive years starting April 1, 2027. Similarly, Ms. Avantika Saraogi has been re-appointed as Executive Director for a five-year term, beginning January 1, 2027. Both appointments are subject to shareholder approval at the upcoming annual general meeting.
Business Segments and Sustainability
The company continues to expand its reach beyond traditional sugar manufacturing. The distillery segment continues to be a key growth driver, supported by the strategic focus on circular economy practices. Furthermore, the company has successfully ventured into bio-plastics through the polylactic acid (PLA) project and the ‘Balrampur Bioyug’ brand. These initiatives highlight the company’s evolution into a diversified business conglomerate with a strong commitment to sustainability and ESG standards.
Future Outlook and Capital Initiatives
Looking ahead, the Board has approved a preferential issue of shares to raise up to ₹45,000 lakh to fuel future growth. This move involves the issuance of up to 9,316,771 equity shares at an issue price of ₹483 per share. This capital infusion is intended to support the company’s ongoing strategic expansion and business operations.
Source: BSE
